Á lódáil...
Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer()()
PURPOSE: To improve the selection of advanced colorectal cancer patients to panitumumab by optimizing the assessment of RAS (KRAS-NRAS) mutations. EXPERIMENTAL DESIGN: Using a centralized pyrosequencing RAS assay, we analyzed the tumors of 94 patients, wild-type for KRAS mutations (codons 12 to 13)...
Na minha lista:
Foilsithe in: | Neoplasia |
---|---|
Main Authors: | , , , , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Neoplasia Press
2014
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4234870/ https://ncbi.nlm.nih.gov/pubmed/25246275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.08.002 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|